GUIDELINES FOR THE SAFE ADMINISTRATION OF INHALED NITRIC-OXIDE

被引:65
作者
MILLER, OI [1 ]
CELERMAJER, DS [1 ]
DEANFIELD, JE [1 ]
MACRAE, DJ [1 ]
机构
[1] HOSP SICK CHILDREN, CARDIOTHORAC UNIT, LONDON WC1N 3JH, ENGLAND
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1994年 / 70卷 / 01期
关键词
D O I
10.1136/fn.70.1.F47
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Inhaled nitric oxide (NO) is a selective pulmonary vasodilator, potentially useful in the treatment of pulmonary hypertension and ventilation-perfusion mismatch. High doses of inhaled NO and its oxidative product nitrogen dioxide (NO2) may cause acute lung injury. Using a standard infant ventilator, ventilator circuit and test lung, an administration and monitoring strategy has been defined for inhaled NO and these observations validated in eight ventilated infants. In 90% oxygen, doses of inhaled NO greater than or equal to 80 parts per million may result in toxic NO2 concentrations.
引用
收藏
页码:F47 / F49
页数:3
相关论文
共 19 条
[1]   RELIEF OF SEVERE PULMONARY-HYPERTENSION AFTER CLOSURE OF A LARGE VENTRICULAR SEPTAL-DEFECT USING LOW-DOSE INHALED NITRIC-OXIDE [J].
BERNER, M ;
BEGHETTI, M ;
RICOU, B ;
ROUGE, JC ;
PRETRE, R ;
FRIEDLI, B .
INTENSIVE CARE MEDICINE, 1993, 19 (02) :75-77
[2]   SAFETY REQUIREMENT FOR USE OF INHALED NITRIC-OXIDE IN NEONATES [J].
BOUCHET, M ;
RENAUDIN, MH ;
RAVEAU, C ;
MERCIER, JC ;
DEHAN, M ;
ZUPAN, V .
LANCET, 1993, 341 (8850) :968-969
[3]   SAFETY GUIDELINES FOR USE OF NITRIC-OXIDE [J].
FOUBERT, L ;
FLEMING, B ;
LATIMER, R ;
JONAS, M ;
ODURO, A ;
BORLAND, C ;
HIGENBOTTAM, T .
LANCET, 1992, 339 (8809) :1615-1616
[4]   INHALED NITRIC-OXIDE - A SELECTIVE PULMONARY VASODILATOR REVERSING HYPOXIC PULMONARY VASOCONSTRICTION [J].
FROSTELL, C ;
FRATACCI, MD ;
WAIN, JC ;
JONES, R ;
ZAPOL, WM .
CIRCULATION, 1991, 83 (06) :2038-2047
[5]   THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[6]   INHALED NITRIC-OXIDE FOR POSTOPERATIVE PULMONARY-HYPERTENSION IN PATIENTS WITH CONGENITAL HEART-DEFECTS [J].
HAYDAR, A ;
MAURIAT, P ;
POUARD, P ;
LEFEBVRE, D ;
MALHERE, T ;
JOURNOIS, D ;
DENIS, N ;
SAFRAN, D ;
VOUHE, P .
LANCET, 1992, 340 (8834-5) :1545-1545
[8]   ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE [J].
IGNARRO, LJ ;
BUGA, GM ;
WOOD, KS ;
BYRNS, RE ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9265-9269
[9]   LOW-DOSE INHALATIONAL NITRIC-OXIDE IN PERSISTENT PULMONARY-HYPERTENSION OF THE NEWBORN [J].
KINSELLA, JP ;
NEISH, SR ;
SHAFFER, E ;
ABMAN, SH .
LANCET, 1992, 340 (8823) :819-820
[10]  
MILLER OI, 1993, J THORAC CARDIOV SUR, V105, P550